Basic Information
Basic information for LINC01814-207-44aa
Peptide Name LINC01814-207-44aa
Genome Position chr2:8570258-8570389[-]
Species Human
Peptide Sequence MSSYFAKAKQTKRINHDRRAPISPRRVSPCCVFICQKSILGSHS
Peptide Length 44
Unique No (LINC01814-202-44aa,LINC01814-208-44aa,LINC01814-209-44aa,LINC01814-210-44aa,LINC01814-212-44aa)
Grand Average of Hydropathicity -0.4705
Relative Molecular Mass 5780.53
Experimental Evidences 2:MS,ribo
lncRNA ID/Name ENSG00000236008;LINC01814
Transcript ID/Name ENST00000655346;LINC01814-207
Transcript Length 1017
Coding Ability 0.4838
DNA Sequence Corresponding to Peptide ATGAGCTCCTACTTCGCGAAAGCAAAACAAACTAAACGCATCAACCACGACCGCAGAGCCCCCATCTCTCCCAGGAGGGTGAGCCCATGTTGTGTTTTCATTTGTCAGAAATCTATCTTAGGAAGCCATTCC
Experimental Evidences
   Mass Spectrometry
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :